![Darren Snellgrove](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darren Snellgrove
Direttore Finanziario/CFO presso
HALOZYME THERAPEUTICS, INC.
Profilo
Darren Snellgrove is Chief Financial Officer at Halozyme Therapeutics, Inc. since 2026.
Formerly, Mr. Snellgrove was Vice President-Investor Relations at Johnson & Johnson from 2025 to 2026.
Education includes an undergraduate degree from The University of Southampton and an MBA from Villanova University.
Posizioni attive di Darren Snellgrove
| Società | Posizione | Inizio |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Direttore Finanziario/CFO | 08/06/2026 |
Precedenti posizioni note di Darren Snellgrove
| Società | Posizione | Fine |
|---|---|---|
| JOHNSON & JOHNSON | Contatto Relazioni con gli Investitori | 07/05/2026 |
Formazione di Darren Snellgrove
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
